Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11Thoracic 1Sarcoma 1Other 1NET 1Gynecologic 1Endocrine 1

Conditions

Neuroendocrine Tumors 3Stomach Neoplasms 1Neoplasms 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1

Interventions

Quality of Life 2tislelizumab 1surufatinib 1regorafenib 1lutetium Lu 177 dotatate 1fludarabine phosphate 1fludarabine 1copper dotatate CU-64 1Surveys and Questionnaires 1Poly(ADP-ribose) Polymerase Inhibitors 1Patient Reported Outcome Measures 1PM 01183 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Lutetium-177 1Lutetium 1Irinotecan 1Immunotherapy 1Fluorodeoxyglucose F18 1FAPI-46 1Drug Therapy 1Cyclophosphamide 1Cryotherapy 1Control Groups 1Clinical Trials, Phase II as Topic 1Biological Therapy 1Betaine 1Acupuncture Therapy 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Surveys and Questionnaires × NET × Clear all
NCT04077372 2023-01-27

Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers

Stanford University

Phase NA Terminated
12 enrolled
EndocrineGastrointestinalNETSarcoma

Esophageal Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡